Amgen (AMGN) PT Raised to $180 at UBS Following Solid 2Q
Tweet Send to a Friend
UBS raised its price target on Amgen (NASDAQ: AMGN) to $180.00 (from $175.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
